MX2011013453A - Agentes antimicrobianos. - Google Patents
Agentes antimicrobianos.Info
- Publication number
- MX2011013453A MX2011013453A MX2011013453A MX2011013453A MX2011013453A MX 2011013453 A MX2011013453 A MX 2011013453A MX 2011013453 A MX2011013453 A MX 2011013453A MX 2011013453 A MX2011013453 A MX 2011013453A MX 2011013453 A MX2011013453 A MX 2011013453A
- Authority
- MX
- Mexico
- Prior art keywords
- relates
- present
- gram
- nucleic acid
- acid molecules
- Prior art date
Links
- 239000004599 antimicrobial Substances 0.000 title abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 4
- 108020001507 fusion proteins Proteins 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 241000192125 Firmicutes Species 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002421 cell wall Anatomy 0.000 abstract 1
- 238000011109 contamination Methods 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000000593 degrading effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000027136 gram-positive bacterial infections Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09163955 | 2009-06-26 | ||
| PCT/EP2010/059152 WO2010149795A1 (en) | 2009-06-26 | 2010-06-28 | Antimicrobial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011013453A true MX2011013453A (es) | 2012-04-11 |
Family
ID=42537604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011013453A MX2011013453A (es) | 2009-06-26 | 2010-06-28 | Agentes antimicrobianos. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20120195872A1 (enExample) |
| EP (2) | EP3363896A1 (enExample) |
| JP (2) | JP6034188B2 (enExample) |
| KR (1) | KR101701890B1 (enExample) |
| CN (1) | CN102482655B (enExample) |
| AU (1) | AU2010264659B2 (enExample) |
| BR (1) | BRPI1015203B1 (enExample) |
| CA (1) | CA2765810C (enExample) |
| EA (1) | EA038542B1 (enExample) |
| IL (1) | IL217121B (enExample) |
| MX (1) | MX2011013453A (enExample) |
| SG (1) | SG177704A1 (enExample) |
| WO (1) | WO2010149795A1 (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3714895A3 (en) | 2009-06-26 | 2020-11-25 | Lysando AG | Antimicrobial agents |
| WO2010149795A1 (en) | 2009-06-26 | 2010-12-29 | Lysando Holding Establishment | Antimicrobial agents |
| EA024253B1 (ru) | 2009-08-24 | 2016-08-31 | Катхолике Университейт Лёвен, К.У. Лёвен Р Энд Д | Литический полипептид с пептидогликангидролазной активностью и его применение против инфекций, вызванных грамотрицательными бактериями |
| PT3443970T (pt) * | 2010-09-17 | 2020-10-09 | Technophage Investig E Desenvolvimento Em Biotecnologia Sa | Fagos antibacterianos, péptidos fágicos e métodos de utilização dos mesmos |
| EP2468856A1 (en) * | 2010-12-23 | 2012-06-27 | Lysando Aktiengesellschaft | Antimicrobial Agents |
| CN102766196B (zh) * | 2011-05-06 | 2014-10-29 | 上海医药工业研究院 | 一组阳离子抗菌肽及其制备方法和应用 |
| CN103361341B (zh) * | 2012-03-26 | 2015-09-02 | 复旦大学附属华山医院 | 杀菌肽ll-37的基因工程的表达及其制备方法和用途 |
| EP2679232A1 (en) * | 2012-06-29 | 2014-01-01 | Lysando Aktiengesellschaft | Composition for use in Mycobacteria vaccination |
| EP2679677A1 (en) * | 2012-06-29 | 2014-01-01 | Lysando Aktiengesellschaft | Composition for use in Mycobacteria therapy |
| WO2014001571A1 (en) * | 2012-06-29 | 2014-01-03 | Lysando Ag | Composition for use in mycobacteria diagnosis |
| CN113717964A (zh) * | 2013-08-06 | 2021-11-30 | 达特茅斯学院理事会 | 非糖基化溶葡球菌素变体蛋白 |
| WO2015070911A1 (en) | 2013-11-14 | 2015-05-21 | Lysando Ag | Modified kz144 endolysin sequence |
| WO2015070912A1 (en) | 2013-11-14 | 2015-05-21 | Lysando Ag | Modified el188 endolysin sequence |
| EP2904912A1 (en) * | 2014-02-07 | 2015-08-12 | Hyglos Invest GmbH | Novel high pressure method with endolysin for processing of foods |
| EP3105322B1 (en) | 2014-02-14 | 2018-12-12 | Lysando AG | Antimicrobial agents |
| US10166253B2 (en) | 2014-08-29 | 2019-01-01 | Region Midtjylland | Positively charged co-polymers for use as antimicrobial agents |
| WO2016130024A1 (en) * | 2015-02-13 | 2016-08-18 | Supreme Biotechnologies Limited | Endolysin expression platform |
| CA3022334A1 (en) * | 2016-04-28 | 2017-11-02 | Lysando Ag | Antimicrobial agents against salmonella bacteria |
| JP7288851B2 (ja) * | 2016-10-20 | 2023-06-08 | ライサンド アーゲー | エンテロコッカス属細菌に対する新規抗微生物剤 |
| US11208643B2 (en) * | 2017-04-03 | 2021-12-28 | Sasinapas Co., Ltd. | Engineered gram-negative endolysins |
| CN108018271B (zh) * | 2018-01-31 | 2020-08-11 | 武汉核圣生物技术有限公司 | 单亚基rna聚合酶、其纯化方法及在rna合成中的应用 |
| CN112368376A (zh) * | 2018-03-29 | 2021-02-12 | 康特拉费克特公司 | 溶素-抗微生物肽(amp)多肽构建体、溶素、其分离的编码多核苷酸及其用途 |
| AU2019276253A1 (en) | 2018-05-30 | 2020-11-26 | Lysando Ag | Novel antimicrobial proteins |
| EP3840771A4 (en) * | 2018-08-23 | 2023-04-19 | Contrafect Corporation | Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof |
| CN115461034B (zh) * | 2020-03-02 | 2024-09-27 | 联合利华知识产权控股有限公司 | 一种有效的抗痤疮个人护理组合物 |
| CN115942932A (zh) | 2020-03-19 | 2023-04-07 | 迈克瑞欧斯人体健康有限公司 | 感兴趣的稳定蛋白 |
| EP4289949A4 (en) | 2021-02-08 | 2024-11-06 | Wuhan Lysigen Bio-Tech Company Limited | BACTERIOPHAGE LYSINE, CHIMERA THEREOF AND ITS APPLICATION |
| WO2022225267A1 (ko) * | 2021-04-19 | 2022-10-27 | 엠브릭스 주식회사 | 보툴리늄 독소 전위 도메인 및 엔도라이신을 포함하는 단백질 복합체 및 이를 포함하는 항균 조성물 |
| AU2023228694A1 (en) * | 2022-03-03 | 2024-09-12 | Massachusetts Institute Of Technology | Cell-wall binding protein specifically targeting cutibacterium acnes |
| CN114540385B (zh) * | 2022-03-21 | 2023-06-23 | 齐鲁工业大学 | 一种利用大肠杆菌产溶葡萄球菌酶的方法 |
| CN114349870B (zh) * | 2022-03-21 | 2022-06-03 | 天津辅元生物医药科技有限公司 | 一种兼具防粘连功效的重组抗菌肽及其制备方法和应用 |
| WO2024241070A1 (en) | 2023-05-22 | 2024-11-28 | L'oreal | Cosmetic composition comprising an endolysin and a polyvinyl alcohol |
| FR3149208A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique, notamment aqueuse, comprenant une endolysine et un pullulane |
| FR3152395A1 (fr) | 2023-08-28 | 2025-03-07 | L'oreal | Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et la 4-hydroxyacetophenone |
| FR3149204A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique comprenant une endolysine et un tensioactif non ionique comprenant un résidu carbohydrate |
| FR3149203A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition anhydre comprenant une endolysine et de l’hydroxypropylmethylcellulose et/ou du pullulane |
| FR3149205A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique comprenant une endolysine et un agent de charge organique |
| FR3149207A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique comprenant une endolysine et un composé de formule (I) |
| FR3149209A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique |
| WO2024246325A1 (en) | 2023-06-02 | 2024-12-05 | L'oreal | Cosmetic composition comprising an endolysin derived from a staphylococcus aureus phage and an aromatic alcohol |
| FR3149206A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique aqueuse comprenant une endolysine et du tréhalose |
| FR3149202A1 (fr) | 2023-06-02 | 2024-12-06 | L'oreal | Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et une huile. |
| FR3152396A1 (fr) | 2023-08-28 | 2025-03-07 | L'oreal | Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un polyhydroxyalcane |
| FR3152394A1 (fr) | 2023-08-28 | 2025-03-07 | L'oreal | Composition cosmétique comprenant une endolysine et des particules d’aérogel de silice hydrophobe |
| FR3152393A1 (fr) | 2023-08-28 | 2025-03-07 | L'oreal | Composition cosmétique comprenant une endolysine dérivée d’un phage de Staphylococcus aureus et une charge minérale |
| WO2025093666A1 (en) | 2023-11-01 | 2025-05-08 | University Of Copenhagen | Treatment of lymphoma |
| CN118421604B (zh) * | 2024-05-27 | 2024-10-22 | 小白鲸(中山)生物医药有限公司 | 一种重组溶葡萄球菌酶突变体及其制备方法和应用 |
| CN119799685A (zh) * | 2024-12-27 | 2025-04-11 | 深圳先进技术研究院 | 一种靶向闪烁梭菌的抗菌蛋白及其制备方法与应用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3854476T2 (de) | 1987-07-06 | 1996-04-04 | Univ Louisiana State | Inhibierung von eukaryotischen pathogenen und neoplasmen mit lytischen peptiden. |
| GB8816693D0 (en) | 1988-07-13 | 1988-08-17 | Agricultural & Food Res | Viral enzyme & gene |
| GB2255561B (en) | 1991-04-20 | 1995-06-21 | Agricultural & Food Res | Lysins from bacteriophages |
| EP0656952B1 (en) | 1992-08-21 | 2003-03-05 | The University Of British Columbia | Cationic peptides and method for production |
| PT778733E (pt) | 1994-09-01 | 2001-06-29 | Novozymes As | Composicao proteica basica para matar ou inibir celulas microbianas |
| US6503881B2 (en) * | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| US6428784B1 (en) | 1997-10-31 | 2002-08-06 | New Horizons Diagnostics Corp | Vaginal suppository for treating group B Streptococcus infection |
| US5997862A (en) | 1997-10-31 | 1999-12-07 | New Horizons Diagnostics Corporation | Therapeutic treatment of group A streptococcal infections |
| US20030113298A1 (en) | 1997-10-31 | 2003-06-19 | Vincent Fischetti | Use of bacterial phage associated lysing proteins for the prophylactic and therapeutic treatment of various illnesses |
| US6288212B1 (en) | 1998-08-28 | 2001-09-11 | The University Of British Columbia | Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
| US5993809A (en) * | 1998-11-18 | 1999-11-30 | Children's Hospital Medical Center | Lysozyme fusion proteins in infections |
| AU5553600A (en) | 1999-06-23 | 2001-01-31 | Ppl Therapeutics (Scotland) Ltd | Fusion proteins incorporating lysozyme |
| US7338936B2 (en) | 2000-11-28 | 2008-03-04 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| KR20050016362A (ko) | 2002-04-22 | 2005-02-21 | 다우 글로벌 테크놀로지스 인크. | 펩티드의 저비용 생산 |
| US7566447B2 (en) | 2003-05-15 | 2009-07-28 | Iogenetics, Llc | Biocides |
| CA2536782A1 (en) | 2003-09-11 | 2005-03-17 | Novozymes A/S | Recombinant production of antimicrobial agents |
| WO2005108563A2 (en) | 2004-04-19 | 2005-11-17 | University Of Chicago | Peptidoglycan-hydrolyzing protein encoded by bacteriophage n4 |
| US7572602B1 (en) | 2004-12-03 | 2009-08-11 | The United States Of America As Represented By The Secretary Of Agriculture | Nucleic acid encoding endolysin fusion protein |
| DE102005040347A1 (de) | 2005-08-25 | 2007-03-01 | Profos Ag | Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von Listerien |
| EP2004215B1 (en) | 2006-03-31 | 2010-06-09 | The University Court of the University of St. Andrews | Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase |
| DE102006061002A1 (de) | 2006-12-22 | 2008-06-26 | Profos Ag | Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von gram-positiven Bakterien |
| EP3327030B1 (en) * | 2007-09-25 | 2021-07-21 | Pastoral Greenhouse Gas Research LTD | Vaccines and vaccine components for inhibition of microbial cells |
| US20100310522A1 (en) | 2007-11-26 | 2010-12-09 | Plant Bioscience Limited | Novel Polypeptides Having Endolysin Activity and Uses Thereof |
| EP2318531A4 (en) | 2008-07-24 | 2011-11-09 | Us Agriculture | TO RESISTANCE DEVELOPMENT REFRACTORY ANTIMICROBIAL ACTIVE SUBSTANCES |
| EP2157100A1 (en) * | 2008-08-19 | 2010-02-24 | Profos AG | Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins |
| GB0815484D0 (en) * | 2008-08-26 | 2008-10-01 | Univ Leuven Kath | Antibacterial agents |
| WO2010091294A2 (en) * | 2009-02-05 | 2010-08-12 | The Regents Of The University Of California | New targeted antimicrobial moieties |
| DE102010014867A1 (de) * | 2009-04-17 | 2010-11-18 | Sms Siemag Ag | Verfahren zum Bereitstellen mindestens einer Arbeitswalze zum Walzen eines Walzguts |
| US8383102B2 (en) | 2009-05-21 | 2013-02-26 | The United States Of America As Represented By The Secretary Of Agriculture | Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens |
| WO2010149795A1 (en) | 2009-06-26 | 2010-12-29 | Lysando Holding Establishment | Antimicrobial agents |
| EP3714895A3 (en) | 2009-06-26 | 2020-11-25 | Lysando AG | Antimicrobial agents |
| EA024253B1 (ru) | 2009-08-24 | 2016-08-31 | Катхолике Университейт Лёвен, К.У. Лёвен Р Энд Д | Литический полипептид с пептидогликангидролазной активностью и его применение против инфекций, вызванных грамотрицательными бактериями |
| DK2563916T3 (en) | 2010-04-27 | 2015-10-05 | Lysando Ag | METHOD FOR REDUCING biofilms |
| WO2014001571A1 (en) * | 2012-06-29 | 2014-01-03 | Lysando Ag | Composition for use in mycobacteria diagnosis |
-
2010
- 2010-06-28 WO PCT/EP2010/059152 patent/WO2010149795A1/en not_active Ceased
- 2010-06-28 KR KR1020127002109A patent/KR101701890B1/ko active Active
- 2010-06-28 US US13/380,329 patent/US20120195872A1/en not_active Abandoned
- 2010-06-28 SG SG2012003745A patent/SG177704A1/en unknown
- 2010-06-28 CN CN201080037886.7A patent/CN102482655B/zh active Active
- 2010-06-28 JP JP2012516777A patent/JP6034188B2/ja active Active
- 2010-06-28 AU AU2010264659A patent/AU2010264659B2/en active Active
- 2010-06-28 BR BRPI1015203-2A patent/BRPI1015203B1/pt active IP Right Grant
- 2010-06-28 EP EP18165516.8A patent/EP3363896A1/en active Pending
- 2010-06-28 MX MX2011013453A patent/MX2011013453A/es active IP Right Grant
- 2010-06-28 CA CA2765810A patent/CA2765810C/en active Active
- 2010-06-28 EA EA201270082A patent/EA038542B1/ru unknown
- 2010-06-28 EP EP10727421.9A patent/EP2446028B1/en active Active
-
2011
- 2011-12-21 IL IL217121A patent/IL217121B/en active IP Right Grant
-
2016
- 2016-07-01 JP JP2016131194A patent/JP2017018092A/ja active Pending
-
2019
- 2019-01-29 US US16/260,407 patent/US11136570B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120061802A (ko) | 2012-06-13 |
| CN102482655B (zh) | 2018-04-10 |
| JP2017018092A (ja) | 2017-01-26 |
| JP6034188B2 (ja) | 2016-11-30 |
| CA2765810C (en) | 2018-10-16 |
| WO2010149795A1 (en) | 2010-12-29 |
| AU2010264659A1 (en) | 2011-12-15 |
| EP2446028A1 (en) | 2012-05-02 |
| IL217121A0 (en) | 2012-02-29 |
| BRPI1015203B1 (pt) | 2021-06-01 |
| US20120195872A1 (en) | 2012-08-02 |
| CN102482655A (zh) | 2012-05-30 |
| SG177704A1 (en) | 2012-02-28 |
| BRPI1015203A2 (pt) | 2016-08-02 |
| EP3363896A1 (en) | 2018-08-22 |
| US11136570B2 (en) | 2021-10-05 |
| AU2010264659B2 (en) | 2016-08-04 |
| US20190218538A1 (en) | 2019-07-18 |
| EA201270082A1 (ru) | 2012-06-29 |
| EA038542B1 (ru) | 2021-09-13 |
| EP2446028B1 (en) | 2018-04-04 |
| KR101701890B1 (ko) | 2017-02-02 |
| IL217121B (en) | 2019-08-29 |
| CA2765810A1 (en) | 2010-12-29 |
| JP2012530510A (ja) | 2012-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011013453A (es) | Agentes antimicrobianos. | |
| MX2011013288A (es) | Agentes antimicrobianos. | |
| MX344257B (es) | Agentes antimicrobianos. | |
| GB201018518D0 (en) | Novel endolysin | |
| AU2010288559A8 (en) | New endolysin OBPgpLYS | |
| WO2010023207A3 (en) | Antimicrobial agents | |
| MX340520B (es) | Metodo de reduccion de biopeliculas. | |
| Wolfmeier et al. | New perspectives in biofilm eradication | |
| JP2014500714A5 (enExample) | ||
| Pane et al. | Identification of novel cryptic multifunctional antimicrobial peptides from the human stomach enabled by a computational–experimental platform | |
| JP2012530510A5 (enExample) | ||
| AU2011206532A8 (en) | Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) | |
| Ho et al. | Bacteriophage endolysins against gram-positive bacteria, an overview on the clinical development and recent advances on the delivery and formulation strategies | |
| NZ603200A (en) | Peptides and their use | |
| MX354047B (es) | Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. | |
| MX2019011808A (es) | Endolisinas de gram-negativas modificadas. | |
| KR102573154B1 (ko) | 변성 펩티드 | |
| EA201991233A1 (ru) | Новый эндолизин | |
| NZ701651A (en) | A bacteriophage for biocontrol of salmonella and in the manufacturing or processing of foods | |
| EP3313862B1 (en) | Broad-spectrum anti-infective peptides | |
| US20240409910A1 (en) | Recombinant polypeptide for use as a medicine, antiseptic agent, antibacterial agent, anti-inflammatory agent, compositions comprising it and uses thereof | |
| LAVIGNE et al. | Antimicrobial agents | |
| Podgórska et al. | FROM A COMMENSAL TO A PATHOGEN–TWO FACES OFSTAPHYLOCOCCUS EPIDERMIDIS | |
| TH120358A (th) | สารต้านจุลินทรีย์ (antimicrobial aggents) | |
| TH142222A (th) | เอ็นโดไลซิน OBPgpLYS ใหม่ (NEW ENDOLYSIN OBPGLYS) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status |
Owner name: ELANCO ANIMAL HEALTH IRELAND LIMITED |
|
| FG | Grant or registration |